LIXTE BIOTECHNOLOGY HOLDINGS, INC. Collaboration Agreements
3 Contracts & Agreements
- Amendment 3 to Development Collaboration Agreement (Filed With SEC on December 2, 2024)
- Amendment 2 to Development Collaboration Agreement (certain portions of this Exhibit have been omitted) (Filed With SEC on October 17, 2023)
- Amendment No. 1 to Development Collaboration Agreement by and between Lixte Biotechnology Holdings, Inc and the Netherlands Cancer Institute, Amsterdam, and the Oncode Institute,... (Filed With SEC on November 9, 2023)
